Peptide knowledge base
PepAxiom
Educational reference on 75peptides and related compounds — what each is, how it works, what it’s studied for, its evidence quality, and its regulatory status. Clinical, precise, no hype. This is information, not medical advice, and contains no dosing.
GLP-1 / metabolic
Blockbuster GLP-1 agonist for diabetes and weight loss.
Dual-incretin agonist with best-in-class weight loss among approved drugs.
Investigational triple agonist producing the largest trial weight loss yet.
Weekly amylin analog, paired with semaglutide for added weight loss.
Dual GLP-1/glucagon agonist targeting MASH and obesity.
First GCG/GLP-1 dual agonist approved (in China) for weight management.
Dual agonist tuned for liver fat and MASH.
Once-daily GLP-1 agonist, predecessor to semaglutide.
First-in-class GLP-1 agonist, derived from Gila monster venom.
Convenient once-weekly GLP-1 agonist for type 2 diabetes.
Short-acting prandial GLP-1 agonist for type 2 diabetes.
Mealtime amylin analog adjunct to insulin.
Investigational brain-acting appetite suppressant (not a peptide).
Failed obesity drug now sold as an unapproved research peptide.
Experimental peptide that kills fat-tissue blood supply; animal-only.
Preclinical NNMT inhibitor marketed for fat loss without human data.
Preclinical exercise-mimetic ERR agonist; mouse data only.
Growth hormone / secretagogues
Selective GH-releasing peptide with no approved medical use.
Short-acting GHRH-analog research peptide, not FDA-approved.
Long-acting GHRH analog; abandoned in development, now research-only.
FDA-approved GHRH analog that reduces visceral fat.
Once-approved GHRH analog, now off-market and compounded only.
Potent synthetic GH-releasing peptide with cardiac receptor activity.
GH-releasing peptide also used as a diagnostic agent abroad.
First-generation GH-releasing peptide known for strong hunger.
Oral GH secretagogue that reliably raises IGF-1.
Recombinant growth hormone; approved for deficiency, misused for anti-aging.
Long-acting IGF-1 analog used as a research anabolic.
Truncated, highly potent short-acting IGF-1 variant.
Muscle-repair IGF-1 splice variant studied preclinically.
Longer-acting pegylated version of Mechano Growth Factor.
Myostatin inhibitor studied for muscle growth.
Healing / repair
Popular gut/tendon-healing research peptide, unapproved in humans.
Thymosin-beta-4-based peptide marketed for healing and recovery.
Common injury-recovery stack of the two healing peptides.
The popular 'Wolverine' injury-recovery stack of BPC-157 and TB-500.
Copper tripeptide with real topical skin-repair evidence.
Copper peptide marketed mainly for hair growth.
Alpha-MSH-derived tripeptide studied for inflammation.
Human antimicrobial peptide with context-dependent effects.
Gut-barrier peptide trialed for celiac disease.
Signaling neuropeptide used in CIRS protocols and trialed in illness.
Approved bladder-pain drug also used off-label for joints.
Non-erythropoietic EPO-derived peptide for nerve/tissue repair.
Cognitive / neuro
Russian nootropic peptide that raises BDNF and neuroplasticity.
Longer-acting, more stable chemical variant of Semax.
Russian anxiolytic peptide modeled on immune peptide tuftsin.
Stabilized, longer-acting variant of Selank.
Porcine-brain peptide mixture with neurotrophic-like effects.
Potent experimental synapse-forming cognitive compound.
Experimental neurogenic peptide derived from CNTF.
Naturally occurring peptide linked to sleep regulation.
Russian short-peptide bioregulator marketed for brain function.
Tetrapeptide claimed to activate telomerase and slow aging.
Longevity / mitochondrial
Central redox coenzyme marketed for energy and anti-aging.
Mitochondria-encoded peptide regulating metabolism via AMPK.
Cardiolipin-targeting peptide that restores mitochondrial function.
Mitochondria-encoded cytoprotective, anti-apoptotic peptide.
Experimental senolytic that clears senescent 'zombie' cells.
Thymus-derived peptide preparation that modulates immunity.
Thymic peptide that modulates immunity; approved in many countries.
Master antioxidant tripeptide used in IV and supplement wellness.
Sexual health / melanocortin
FDA-approved melanocortin agonist for low sexual desire in women.
Melanocortin agonist; approved as Scenesse for a rare photodermatosis.
Unapproved tanning/libido peptide with notable safety risks.
Peptide that triggers GnRH release to drive reproductive hormones.
'Bonding' hormone; FDA-approved for labor and postpartum use.
Synthetic GnRH used diagnostically and to stimulate gonadotropins.
Pregnancy hormone; FDA-approved to stimulate gonadal function.
MC4R agonist approved for rare genetic and hypothalamic obesity.
Cosmetic / skin
Topical octapeptide marketed to soften expression wrinkles.
Popular topical 'Botox-in-a-jar' wrinkle peptide.
Topical peptide that signals skin to build collagen.
Injectable blend marketed for skin, healing and recovery.
Glow-style blend plus the anti-inflammatory tripeptide KPV.
Educational information only — not medical advice. Many compounds listed are not FDA-approved for human use; evidence quality and legal status vary and are noted on each profile. No dosing information is provided.